Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cancer Genetics to acquire Gentris Corp


Monday, 23 Jun 2014 08:37am EDT 

Cancer Genetics Inc:Signs non-binding Letter of Intent (LOI) to acquire privately held Gentris Corporation.For consideration of about $4.75 mln, comprised of $3.25 mln in cash, $1.5 mln in CGI stock as well as additional performance-based earnouts of up to $1.5 mln.Transaction expected to close during the third quarter of 2014. 

Company Quote

7.54
0.35 +4.87%
19 Dec 2014